Inventor · disambiguated record
Changyi Chen
Also filed as: CHEN CHANGYI · CHEN CHANGYI JOHNNY
18 granted patents·8 pending applications·112 citations·filing 2001–2024
93Inventor score
Top patents by PatentIndex Score
26 records- 0196US8895626B1Small molecule xanthine oxidase inhibitors and methods of useBAYLOR COLLEGE MEDICINE·Filed 2014·Granted Nov 25, 2014·8 cites·6 claims
- 0293US8883858B1Small molecule xanthine oxidase inhibitors and methods of useBAYLOR COLLEGE MEDICINE·Filed 2014·Granted Nov 11, 2014·4 cites·7 claims
- 0392US8987337B2Small molecule xanthine oxidase inhibitors and methods of useBAYLOR COLLEGE MEDICINE·Filed 2014·Granted Mar 24, 2015·3 cites·3 claims
- 0491US9546365B2MicroRNA-198 as a tumor suppressor in ovarian cancerBAYLOR COLLEGE MEDICINE·Filed 2015·Granted Jan 17, 2017·5 cites·25 claims
- 0591US8883857B2Small molecule xanthine oxidase inhibitors and methods of useBAYLOR COLLEGE MEDICINE·Filed 2013·Granted Nov 11, 2014·3 cites·3 claims
- 0689US12134769B2MicroRNA-198 as a tumor suppressor in ovarian cancerBAYLOR COLLEGE MEDICINE·Filed 2021·Granted Nov 5, 2024·1 cites·10 claims
- 0789US11008573B2MicroRNA-198 as a tumor suppressor in ovarian cancerBAYLOR COLLEGE MEDICINE·Filed 2019·Granted May 18, 2021·2 cites·12 claims
- 0889US2025092402A1Microrna-198 as a tumor suppressor in ovarian cancerBAYLOR COLLEGE MEDICINE·Filed 2024·Application pending·0 cites
- 0986US6689161B2Decellularized vascular prostheses resistant to thrombus occlusion and immunologic rejectionBAYLOR COLLEGE MEDICINE·Filed 2001·Granted Feb 10, 2004·49 cites·15 claims
- 1082US8987224B2MicroRNA-198 as a tumor suppressor in pancreatic cancerYAO QIZHI·Filed 2012·Granted Mar 24, 2015·3 cites·33 claims
- 1181US7060022B2Decellularized vascular prostheses resistant to thrombus occlusion and immunological rejectionBAYLOR COLLEGE MEDICINE·Filed 2003·Granted Jun 13, 2006·32 cites·10 claims
- 1276US10246560B2PLGA-modified polyethylenimine self-assembly nanotechnology for nucleic acid and drug deliveryBAYLOR COLLEGE MEDICINE·Filed 2014·Granted Apr 2, 2019·2 cites·4 claims
- 1376US9610257B2Small molecule xanthine oxidase inhibitors and methods of useBAYLOR COLLEGE MEDICINE·Filed 2014·Granted Apr 4, 2017·0 cites·7 claims
- 1474US9622988B2Small molecule xanthine oxidase inhibitors and methods of useBAYLOR COLLEGE MEDICINE·Filed 2014·Granted Apr 18, 2017·0 cites·1 claims
- 1574US9585847B2Small molecule xanthine oxidase inhibitors and methods of useBAYLOR COLLEGE MEDICINE·Filed 2014·Granted Mar 7, 2017·0 cites·2 claims
- 1674US9585848B2Small molecule xanthine oxidase inhibitors and methods of useBAYLOR COLLEGE MEDICINE·Filed 2014·Granted Mar 7, 2017·0 cites·2 claims
- 1774US9061983B2Methods of inhibiting xanthine oxidase activity in a cellBAYLOR COLLEGE MEDICINE·Filed 2014·Granted Jun 23, 2015·0 cites·1 claims
- 1867US11613609B2PLGA-modified polyethylenimine self-assembly nanotechnology for nucleic acid and drug deliveryBAYLOR COLLEGE MEDICINE·Filed 2019·Granted Mar 28, 2023·0 cites·20 claims
- 1966US2017081666A1Microrna-198 as a tumor suppressor in ovarian cancerBAYLOR COLLEGE MEDICINE·Filed 2016·Application pending·0 cites
- 2066US2016089342A1Method of inhibiting xanthine oxidase activity in a cellBAYLOR COLLEGE MEDICINE·Filed 2015·Application pending·0 cites
- 2158US2018346914A1Microrna-198 as a tumor suppressor in ovarian cancerBAYLOR COLLEGE MEDICINE·Filed 2018·Application pending·0 cites
- 2255US2023346765A1Methods of treating xanthine oxidase-related diseases with niflumic acid and derivatives thereofBAYLOR COLLEGE MEDICINE·Filed 2021·Application pending·0 cites
- 2353US2021386812A1Development of health food supplements and antioxidants for controlling hyperuricemia and oxidative stressBAYLOR COLLEGE MEDICINE·Filed 2019·Application pending·0 cites
- 2449US9580379B2Xanthine oxidase inhibitors and methods of useBAYLOR COLLEGE MEDICINE·Filed 2014·Granted Feb 28, 2017·0 cites·9 claims
- 2546US2013295160A1Antagonists of mir-196aBAYLOR COLLEGE MEDICINE·Filed 2013·Application pending·0 cites
- 2645US2013259926A1BI-FUNCTIONAL shRNA TARGETING MESOTHELIN AND USES THEREOFGRADALIS INC·Filed 2013·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →